Related Tags >> Arthritis Roche Genentech Enbrel

rheumatoid arthritis News

Most Popular rheumatoid arthritis Story

SPOTLIGHT: Insurers hike co-pays for expensive meds

April 14, 2008 — 6:59am ET

Health insurers are passing on the high cost of some meds to patients, asking them to pay up to one-third the price of expensive drugs; the policies affect drugs for such serious illnesses as... Read more...

rheumatoid arthritis Press Releases

Velcura Therapeutics, Inc. to Begin Clinical Trials in Rheumatoid Arthritis Patients
New data shows ACTEMRA inhibits progression of joint destruction and improves physical function of patients with Rheumatoid Arth
Biogen Idec Announces Top-Line Results from Phase II Clinical Trial of Baminercept in Rheumatoid Arthritis
VGX Pharmaceuticals Commences Follow-on Phase I Study for Novel Oral Anti-Inflammatory Drug Targeting Rheumatoid Arthritis and T
Researchers discover how rheumatoid arthritis causes bone loss

Latest Headlines

Roche drug touted at rheumatology confab
October 27, 2008
Rituxan patient dies from PML
September 12, 2008
Advisory Panel recommends Actemra to FDA
July 30, 2008
Study: Enbrel plus methotrexate helps RA
July 16, 2008
UCB's Cimzia app gets data boost
June 12, 2008
FDA stresses dangers of transplant meds
May 19, 2008
ALSO NOTED: Forest takes charge on Azor split; GSK launches Tykerb-Herceptin trials;
May 13, 2008
Enbrel gets black-box infection warning
May 2, 2008
SPOTLIGHT: Rituxan falls short in lupus trial
April 30, 2008
As former exec indicted, BMS posts growth
April 24, 2008
ALSO NOTED: GSK to invest $47M in Irish plant; AstraZeneca, GSK get downgraded;
April 18, 2008
ALSO NOTED: J&J reports big revenue growth; Drugmakers fight U.K.'s Aricept ruling;
April 15, 2008
SPOTLIGHT: Insurers hike co-pays for expensive meds
April 14, 2008
BMS, Repligen settle Orencia fight
April 8, 2008

Paid Research Reports

More Research Reports >>